Race against time: new trial attacks MS within days of first symptoms
NCT ID NCT05418010
Summary
This study tests if starting a powerful MS medication called Tyruko (natalizumab) within just 14 days of a person's first MS-like symptoms leads to better nerve repair. It will involve 40 UK adults who have recently shown signs of MS. Researchers will use special brain scans to see if this ultra-early treatment helps the nervous system heal itself more effectively than waiting for standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal London Hospital
NOT_YET_RECRUITINGLondon, E1 1FR, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St George's Hospital
RECRUITINGLondon, SW17 0QT, United Kingdom
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.